Digitizer firm finds new home

Article

Vidar System, widely known as a manufacturer of medical film digitizers, has been acquired by Contex Holdings of Allerød, Denmark. Contex, a maker of large-format scanners, is owned by EQT, a group of Scandinavian private equity funds. Contex and Vidar

Vidar System, widely known as a manufacturer of medical film digitizers, has been acquired by Contex Holdings of Allerød, Denmark. Contex, a maker of large-format scanners, is owned by EQT, a group of Scandinavian private equity funds. Contex and Vidar have been competitors in the development and distribution of large-format image scanning equipment. Vidar has also established itself as the leading producer of medical x-ray digitizers for diagnosis and treatment applications. The merged company will have combined revenues for 2002 exceeding US$50 million. Strategists plan to focus on the medical imaging products segment, while Contex concentrates on large-format imaging applications. Vidar will continue to design, develop, and distribute its range of medical products under Vidar brand from its facility in Herndon, VA.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.